Document 2JZmVdyp7yXpxapoo7G78J7k6

CHEMICAL MANUFACTURERS ASSOCIATION Vinyl Chloride Panel Vinyl Chloride Research Coordinators Tentative Agenda DATE: TIME: PLACE: May 19, 1994 10:00 a.m. - 3:00 p.m., EDT CMA Offices 2501 M Street, NW Washington, D.C. 1.0 Approval of February 14, 1994 Record of Meeting 2.0 Discussion of Scope of Work of the Epidemiology Study 3.0 Discussion of Potential Contractors for the Epidemiology Study 4.0 Discussion of Cost Sharing Formula for the Epidemiology Study 5.0 Presentation by Richard Reitz on Predicting Cancer Risk from Vinyl Chloride Exposure with a Physiologically-Based Pharmacokinetic Model - TENTATIVE 6.0 Discussion of Course of Action with EPA on Vinyl Chloride Risk Assessment 7.0 Discussion of ATSDR Research Data Needs for Vinyl Chloride 8.0 Discussion of Course of Action with ATSDR on Its Priority Data Needs 9.0 Financial Statement 10.0 Schedule Date for Next Meeting or Conference Call Subject to Approval Hasmukh C. Shah, Ph.D. Manager, Vinyl Chloride Panel BFG 00197 ANTITRUST CHECKLIST FOR CMA MEETINGS This antitrust checklist is for use by CMAscaffand member representathvs in ihe conduct of CMA-sponsored meetings. Pro hibited discussion topics apply equally to social gatherings inddenoJ to CMA-sponsored meetings. The Checklist Is not haustive and does not address antitrust issues relating to activities other than CMA meetings. Participants in CMA meetings should be thoroughly familiar with: (1) "Antitrust Guide for CMA Committee Members;" and, (2) "General Principles Applica ble to die Structure and Operations of Committees." Both of these documents may be found in the CMA Directory. DO Ensure stria performance in areas of: OVEBSIGHrSUPEKVlSlONi Have t CMA staffrepresentative at each CMA-sponsored meet ing (unless an exception has been aixhorized by the appropriate CMA vice-president); consufr with an anomeyofthe CM* Office ofGenera/Counsel an mB antitrust questions relating to CMA-sponsored meet* hmu meeting discussions to agenda topics (unless addMcmal topics have been approved by the appropriate OiA saff rep resentative), and provide each member company representative and Q4A staff representative attending a CMA-sponsored meeting wfrh a copy of this checklist, and have a copy available for reference at aD CMA-sponsored meetings. RECORDKEEPING: Hre an agenda and minutes which accurately reflect the mat ters which occur provide agendas and minutes to the Q4A Office of General Counsel for review and approval in advance of dUsffiudont and. fuDv describe the purposes and authorities of aB task groups, work groups, ad hoc or ocher standing committee subgroups in the minutes of the appropriate parent comminee. VIGILANCE: Protest against any discussion or meeting activities which ap pear to violate this checklist; disassociate yourself from any such discussion or activities and leave any meeting in which they continue. Revised 3'80 (single page version) Reformated 1/89 MDB DON'T Do not infaaoc appearance, discuss or exchange infor mation on: mCXS, INOUDlNGt Individual company prices, price changes, price differentials, markups, discounts, allowances, credit terms, etc.; Individual comply data on casts, production, capacity. ffivenrotica. ales, etc; and industry pricing policies, price levels, price change*. differen tials, etc production, ntcmscNGi Hans ofindividual companies concerning the design, produc tion, diwlbtaion or marketing of particular products, mduding proposed ternaries or customets; and. changes m industry production, capacity or inventories. TRANSPORTATION KATES: Kates or rate policies lor individual shipments, including bas ing point systems, zone prices, freight equalization, etc. MARKET PROCEDURES, INCLUDING! Company bids on conusus for particular products: company procedures for responding to bid invitations; and, matters relating to actual or potential individual suppliers or customets that might have the effect of excluding them from any market or influencing the business conduct of firms to ward them. CONSENT DECREE SUBSTANCXi Any matter relating to thsodium phosphate (a restncikv quired by a 1962 consent decree to which CMA is a parry). BFG 00198